Defence Research and Development Organisation (DRDO) has developed an antibody detection-based kit ‘DIPCOVAN’, the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA for sero-surveillance.
- The kit will be very useful for understanding COVID‐19 epidemiology and assessing an individual’s previous SARS‐CoV‐2 exposure.
- The kit can detect both spike as well as nucleocapsid proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent.
- The kit has been developed in association with Vanguard Diagnostics Private Limited, a development and manufacturing diagnostics company based at New Delhi.
- The DIPCOVAN kit was developed indigenously by the scientists, followed by extensive validation on more than one thousand patient samples at various COVID designated hospitals in Delhi.
